syndrom
panel
pointofcar
molecular
diagnost
multiplex
pcr
group
streptococcu
influenzalik
ill
mening
gastroenter
blood
stream
infect
syndrom
pointofcar
molecular
diagnost
test
method
revolution
infecti
diseas
test
permit
simultan
detect
multipl
pathogen
drug
resist
mechan
directli
clinic
specimen
posit
blood
cultur
syndrom
test
panel
current
includ
design
detect
pathogen
respons
bloodstream
central
nervou
system
gastrointestin
tract
respiratori
tract
infect
well
biothreat
agent
pointofcar
molecular
diagnost
system
afford
provid
abil
gener
laboratoryqu
result
without
need
confirmatori
test
neg
specimen
implement
syndrom
pointofcar
molecular
infecti
diseas
test
method
curb
unnecessari
use
antibiot
strengthen
antimicrobi
stewardship
practic
develop
method
detect
infecti
diseas
beyond
detect
current
technolog
area
investig
decad
clinic
laboratori
diagnosi
mani
infecti
diseas
reli
sole
timeconsum
often
laborintens
manual
cultivationbas
microscop
immunoserolog
method
requir
experienc
technic
personnel
perform
interpret
introduct
semiautom
fulli
autom
microbi
phenotyp
system
later
part
centuri
vastli
improv
process
bacteri
yeast
isol
workup
decreas
identif
antimicrobi
suscept
test
turnaround
time
tat
howev
detect
mani
virus
parasit
still
requir
tradit
techniqu
subsequ
improv
autom
platform
includ
refin
autom
expert
system
use
devic
gener
interpret
data
led
decreas
tat
concomit
increas
cultur
throughput
era
molecular
diagnost
usher
introduct
nucleic
acid
analysi
method
includ
hybrid
protect
assay
eg
accuprob
salem
identif
isol
polymeras
chain
reaction
pcr
detect
pathogen
directli
patient
specimen
later
implement
realtim
nucleic
acid
amplif
chemistri
permit
faster
pathogen
detect
enabl
nucleic
acid
quantit
method
quickli
migrat
research
laboratori
clinic
laboratori
first
laboratorydevelop
test
socal
home
brew
test
revolut
enabl
laboratorian
precis
identifi
caus
infecti
diseas
detect
pathogenspecif
nucleotid
sequenc
cultur
isol
clinic
specimen
mani
method
prove
far
superior
term
accuraci
result
tat
compar
cultivationdepend
approach
especi
identif
virus
time
method
also
underw
refin
includ
adapt
sever
assay
autom
platform
allow
user
minim
manual
handl
specimen
reaction
compon
one
recent
advanc
pathogen
detect
syndrom
approach
group
pathogen
test
simultan
singl
reaction
vessel
assay
incorpor
compon
older
method
includ
realtim
pcr
howev
rather
order
separ
test
variou
pathogen
syndrom
test
allow
simultan
detect
varieti
agent
associ
specif
diseas
syndrom
newest
system
allow
user
perform
laboratoryqu
molecular
test
point
patient
care
major
advanc
move
molecular
patholog
forefront
modern
diagnost
mani
clinic
laboratori
improv
amend
clia
waiv
pointofcar
poc
system
avail
permit
rapid
result
report
enabl
prescript
target
treatment
time
clinic
visit
current
assay
platform
larg
target
infect
diagnos
ambulatori
set
influenza
streptococc
pharyng
syndrom
poc
molecular
test
method
revolution
diagnosi
infecti
diseas
increas
accuraci
microbi
detect
substanti
decreas
time
need
gener
clinic
use
laboratori
test
result
enabl
perform
laboratoryqu
test
near
point
care
nonlaboratorian
return
patient
abl
receiv
appropri
treatment
sooner
avoid
prolong
exposur
unnecessari
antimicrobi
drug
therebi
avoid
select
drugresist
pathogen
strengthen
antimicrobi
stewardship
practic
addit
mani
method
permit
rapid
detect
pathogen
pose
signific
infect
control
public
health
hazard
includ
highconsequ
travelrel
pathogen
eg
bacillu
anthraci
ebola
viru
plasmodium
spp
associ
either
natur
acquir
infect
infect
result
deliber
releas
agent
consequ
rapid
tat
test
contain
epidemiolog
intervent
institut
soon
specimen
acquisit
addit
syndrom
poc
molecular
test
solut
avail
aid
identif
pathogen
mani
test
panel
also
capabl
detect
antimicrobi
resist
mechan
rapid
detect
afford
clinician
infect
control
practition
abil
quickli
implement
appropri
therapi
infect
control
precaut
diagnost
power
technolog
coupl
user
friendli
made
highli
attract
altern
tradit
method
reli
procur
isol
consequ
method
viral
cultur
direct
immunofluoresc
larg
disappear
modern
clinic
microbiolog
laboratori
method
remov
mani
laboratori
streamlin
workup
clinic
specimen
use
one
syndrom
test
platform
analysi
varieti
specimen
type
larg
array
pathogen
current
numer
diagnost
product
manufactur
market
infecti
diseas
syndrom
panel
poc
molecular
test
avail
varieti
format
includ
customiz
panel
singleanalyt
test
cliawaiv
moder
complex
system
test
design
provid
advantag
tradit
molecular
diagnost
test
offer
plu
benefit
rapid
result
deliveri
portabl
eas
use
abil
mani
test
platform
success
use
nonlaboratorian
made
amen
deploy
patient
care
facil
clinic
hospit
emerg
depart
tradit
staf
medic
laboratori
scientist
sever
syndrom
poc
test
system
provid
qualit
result
describ
herein
pleas
note
avail
system
mention
visibl
market
presenc
unit
state
discuss
current
avail
syndrom
panel
platform
bd
max
system
bd
diagnost
quebec
canada
fig
autom
realtim
pcr
platform
use
taqman
hydrolysi
probe
detect
addit
syndrom
panel
see
tabl
tabl
system
design
run
singleplex
userdefin
assay
perform
test
specimen
sampl
buffer
reagent
extract
well
pipett
tip
realtim
pcr
microfluid
cartridg
place
board
bd
max
instrument
autom
sampl
handl
realtim
pcr
step
see
fig
assay
run
simultan
result
avail
within
hour
panel
perform
characterist
review
ref
eplex
eplex
np
system
genmark
diagnost
inc
carlsbad
ca
fig
use
patent
esensor
technolog
detect
varieti
pathogen
directli
patient
specimen
eplex
eplex
np
system
amplifi
nucleic
acid
mixtur
esensor
system
eplex
system
specimen
buffer
solut
ad
eplex
panel
liquid
handl
step
perform
digit
microfluid
technolog
electrowet
electrochem
detect
ferrocenelabel
pcr
amplicon
occur
via
captur
probe
immobil
goldplat
electrod
result
gener
avail
within
minut
anywher
assay
ran
simultan
depend
instrument
configur
eplex
np
perform
maximum
test
contrast
esensor
system
predecessor
eplex
system
design
simultan
interrog
sampl
undergon
offlin
nucleic
acid
amplif
result
avail
within
minut
analyt
detect
current
panel
list
tabl
perform
characterist
impact
system
discuss
ref
filmarray
system
biofir
diagnost
biofir
defens
llc
salt
lake
citi
ut
fig
famili
syndrom
panel
includ
sever
assay
clear
us
food
drug
administr
fda
sever
research
use
assay
box
see
tabl
tabl
note
biofir
defens
offer
researchuseonli
reagent
panel
design
detect
highconsequ
emerg
pathogen
whose
detect
could
signal
possibl
bioterror
event
pathogen
associ
travel
area
world
certain
infecti
diseas
rare
unit
state
endem
tabl
filmarray
system
incorpor
lyophil
reagent
assay
reaction
vessel
small
plastic
abbrevi
ctgcvt
chlamydia
trachomatisgonococcu
neisseria
gonorrhoea
trichomona
vaginali
fda
us
food
drug
administr
symbol
ye
present
panel
absent
panel
bd
max
vagin
panel
detect
candida
albican
c
dubliniensi
c
glabrata
c
krusei
c
parapsilosi
c
tropicali
report
candida
group
except
c
glabrata
c
krusei
report
individu
b
bd
max
vagin
panel
detect
lactobacillu
crispatu
l
jensenii
group
lactobacillu
speci
c
detect
bacteri
analyt
report
posit
neg
bacteri
vaginosi
film
pouch
top
solid
plastic
reagent
hous
fig
reagent
rehydr
sampl
buffer
ad
pouch
load
filmarray
instrument
autom
nucleic
acid
extract
realtim
pcr
detect
highresolut
melt
step
handson
time
system
minim
approxim
minut
result
gener
avail
approxim
minut
like
unyvero
lower
respiratori
tract
panel
cureti
usa
inc
san
diego
ca
fig
known
pneumonia
panel
europ
first
multiplex
lower
respiratori
tract
infect
test
system
receiv
fda
clearanc
april
system
use
pcr
detect
array
bacteri
pathogen
antimicrobi
resist
gene
tabl
directli
tracheal
aspir
hour
unyvero
system
compos
hardwar
compon
sampl
lysi
devic
unyvero
lysat
panel
analyz
unyvero
analyz
touchscreen
comput
interfac
barcod
scanner
unyvero
cockpit
perform
characterist
describ
ref
tabl
cartridg
analyt
tip
holder
assembl
util
tray
load
processor
sp
autom
nucleic
acid
extract
purif
target
amplif
requir
specif
assay
hybrid
target
molecul
glass
detect
array
test
cartridg
nanogrid
technolog
use
captur
detect
identifi
target
molecul
process
step
test
cartridg
array
place
verigen
reader
obtain
result
may
select
report
total
handson
autom
process
test
interpret
time
less
hour
perform
characterist
describ
ref
eplex
rp
esensor
rvp
c
filmarray
rp
panel
filmarray
panel
filmarray
rp
ez
nxtag
rpp
b
verigen
rp
flex
b
c
addit
verigen
system
luminex
offer
fdaclear
bead
hybridizationbas
xtag
assay
requir
offlin
nucleic
acid
extract
follow
multiplex
pcr
bead
hybrid
plate
analysi
bead
carri
magpix
instrument
fig
magpix
instrument
interrog
bead
well
reaction
plate
detect
fluoresc
report
link
beadhybrid
target
molecul
total
time
requir
perform
run
approxim
hour
batch
test
sampl
requir
nxtag
nextgener
respiratori
pathogen
panel
allow
user
select
report
analyt
see
tabl
wherea
xtag
gastrointestin
pathogen
panel
see
tabl
see
ref
perform
characterist
syndrom
panel
blood
cultur
accur
diagnosi
earli
appropri
treatment
sepsi
lifesav
event
syndrom
panel
design
use
exponenti
growth
organ
brothbas
blood
cultur
system
detect
common
caus
bacteremia
key
resist
mechan
would
alter
therapeut
manag
eg
methicillin
resist
perform
system
thoroughli
review
elsewher
note
filmarray
verigen
correctli
detect
identifi
organ
monomicrobi
cultur
compar
convent
method
achil
heel
blood
cultur
syndrom
panel
miscal
associ
polymicrobi
cultur
specif
error
associ
antimicrobi
resist
infecti
mening
enceph
often
medic
emerg
requir
prompt
accur
diagnosi
intervent
favor
outcom
cultur
suboptim
detect
mani
etiolog
howev
laboratori
lack
infrastructur
perform
laboratorydevelop
molecular
test
therefor
reli
refer
laboratori
viral
detect
cerebrospin
fluid
patient
antimicrobi
widespread
earli
adopt
plagu
concern
around
perform
set
misdiagnosi
could
catastroph
respiratori
panel
correl
result
without
sensit
specif
gold
standard
challeng
multicent
evalu
establish
high
percent
agreement
compar
test
howev
percent
agreement
posit
result
furthermor
report
falseneg
eg
potenti
suboptim
detect
herpesvirus
cryptococcu
falseposit
result
eg
streptococcu
pneumonia
herp
simplex
result
delay
miss
mening
diagnos
acut
gastroenter
present
clinic
public
health
dilemma
symptom
infecti
noninfecti
caus
diarrhea
overlap
tradit
diagnost
eg
cultur
microscopi
antigen
detect
time
consum
may
requir
multipl
specimen
optim
sensit
studi
reproduc
shown
time
pathogen
detect
molecular
assay
use
compar
tradit
method
due
part
enhanc
rang
target
increas
sensit
assay
tradit
method
recognit
coinfect
previous
unrecogn
sensit
specif
assay
overal
high
except
notabl
detect
rotaviru
campylobact
spp
salmonella
spp
may
problemat
verigen
one
public
note
parasit
panel
filmarray
gi
panel
verigen
ep
test
b
xtag
gpp
c
filmarray
gi
panel
detect
campylobact
jejuni
c
coli
c
upsaliensi
report
campylobact
jejuni
coli
upsaliensi
shigella
spp
report
along
e
coli
eiec
shigellaenteroinvas
e
coli
eiec
v
cholera
v
parahaemolyticu
v
vulnificu
detect
report
vibrio
parahaemolyticu
vulnificu
cholera
howev
v
cholera
also
report
independ
alon
detect
noroviru
genogroup
ii
detect
astroviru
genotyp
ii
iv
v
detect
b
verigen
ep
test
detect
c
jejuni
c
coli
c
lari
report
campylobact
group
shigella
boydii
dysenteria
flexneri
sonnei
detect
report
shigella
spp
v
cholera
v
parahaemolyticu
detect
report
vibrio
group
noroviru
genogroup
ii
detect
c
xtag
gpp
detect
c
jejuni
c
coli
c
lari
report
campylobact
cryptosporidium
parvum
c
homini
report
cryptosporidium
boydii
dysenteria
flexneri
sonnei
report
shigella
biothreat
panel
c
filmarray
global
fever
panel
e
fals
posit
noroviru
use
biofir
overal
platform
allow
time
accur
diagnosi
diarrhea
assist
pathogendirect
therapi
owe
rel
pauciti
accur
rapid
diagnost
pathogen
determin
acut
respiratori
ill
tradit
fallen
clinic
present
despit
poor
prognost
valu
rapid
accur
diagnosi
critic
antibiot
stewardship
inform
clinician
antivir
warrant
infect
control
initi
eg
isol
cohort
unsurprisingli
respiratori
ill
key
target
syndrom
test
see
tabl
perform
characterist
review
depth
elsewher
key
attribut
highlight
herein
commerci
avail
respiratori
panel
significantli
outperform
tradit
method
detect
expand
recognit
coinfect
approxim
sampl
test
present
gold
standard
method
comparison
assay
hamper
exact
determin
perform
howev
gener
accept
overal
agreement
molecular
method
target
except
accur
detect
adenoviru
problemat
mani
firstgener
assay
howev
multicent
analysi
filmarray
indic
increas
sensit
assay
sexual
transmit
infect
bacteri
vaginosi
vagin
yeast
infect
associ
signific
morbid
longterm
consequ
includ
infertil
diagnosi
highli
preval
infecti
diseas
requir
use
multipl
test
method
microscopi
cultur
nucleic
acid
amplif
test
howev
advent
syndrom
test
system
pathogen
eg
bd
max
ctgctv
bd
max
vagin
panel
see
tabl
streamlin
detect
overal
assay
list
tabl
outperform
tradit
method
includ
chlamydia
trachomati
cultur
microscop
screen
bacteri
vaginosi
candidiasi
trichomoniasi
one
studi
evalu
perform
bd
max
ctgctv
assay
sensit
detect
three
analyt
greater
specif
greater
accord
clinic
trial
data
bd
max
vagin
panel
sensit
analyt
rang
analyt
collect
method
candida
glabrata
cliniciancollect
specimen
c
glabrata
simul
specimen
candida
krusei
simul
specimen
specif
rang
bacteri
vaginosi
selfcollect
specimen
c
glabrata
simul
specimen
c
krusei
selfcollect
simul
specimen
overal
sexual
transmit
infectionwomen
health
syndrom
panel
outperform
tradit
method
term
sensit
specif
tat
push
get
faster
diagnost
answer
guid
admiss
discharg
strategi
therapeut
like
propel
multiplex
test
realm
poc
test
present
issu
contamin
qualiti
control
perform
monitor
interpret
result
overal
good
laboratori
practic
technolog
migrat
less
control
set
obviou
concern
current
cliawaiv
platform
discuss
briefli
system
may
readili
adapt
multiplex
syndrom
test
poc
set
aler
aler
scarborough
inc
scarborough
fig
system
use
nick
enzym
amplif
reaction
technolog
isotherm
amplif
method
detect
nucleic
acid
target
pathogen
includ
influenza
b
virus
respiratori
syncyti
viru
group
streptococcu
either
directli
swab
swab
eluat
transport
media
consum
system
consist
reagent
base
elut
buffer
contain
transfer
cartridg
assembl
aler
instrument
posit
result
avail
within
minut
depend
assay
type
perform
characterist
addit
detail
describ
ref
coba
liat
system
roch
diagnost
indianapoli
fig
integr
reagent
necessari
nucleic
acid
purif
amplif
realtim
pcr
segment
soft
plastic
tube
hous
within
rigid
plastic
frame
specimen
collect
eg
nasopharyng
swab
elut
suitabl
specimen
transport
medium
eg
viral
transport
medium
small
aliquot
specimen
pipet
tube
tube
cap
entir
tubefram
assembl
load
coba
liat
instrument
autom
reaction
amplicon
detect
step
result
influenza
detect
avail
within
minut
group
streptococcu
avail
within
minut
assay
initi
current
three
fdaclear
cliawaiv
assay
avail
detect
influenza
ab
virus
alon
influenza
ab
virus
respiratori
syncyti
viru
group
streptococcu
perform
characterist
discuss
ref
solana
system
quidel
corpor
san
diego
ca
fig
use
isotherm
helicasedepend
amplif
fluorescentprob
detect
target
nucleic
acid
current
fdaapprov
assay
avail
detect
clostridium
difficil
group
b
streptococci
herp
simplex
virus
varicellazost
viru
influenza
virus
respiratori
syncyti
viru
human
metapneumoviru
trichomona
vaginali
perform
test
patient
specimen
eg
nasal
swab
viral
transport
medium
process
buffer
heat
transfer
reaction
tube
reaction
tube
contain
reagent
need
amplif
detect
lyophil
form
reaction
tube
next
insert
solana
instrument
amplif
detect
perform
result
avail
minut
less
solana
diagnost
assay
analyz
simultan
relev
perform
characterist
describ
ref
assay
packag
insert
avail
quidel
websit
http
wwwquidelcom
system
plu
describ
herein
constantli
undergo
refin
ensur
continu
relev
molecular
diagnost
marketplac
test
system
continu
challeng
new
strain
pathogen
antimicrobi
resist
mechan
evalu
inclus
exclus
panel
frequent
updat
includ
addit
analyt
also
new
assay
enabl
detect
quantit
pathogen
associ
diseas
process
besid
mention
previous
develop
goal
manufactur
offer
infecti
diseas
diagnost
test
solut
allow
identif
greatest
breadth
pathogen
associ
specif
diseas
process
syndrom
end
futur
applic
technolog
includ
enhanc
current
avail
system
develop
addit
panel
amen
diagnosi
infecti
process
develop
test
enabl
user
comprehens
profil
antimicrobi
suscept
pathogen
use
multiplex
panel
pathogen
detect
provid
sever
advantag
tradit
laboratori
diagnost
approach
provid
tout
multiplex
assay
mean
simplifi
order
process
decreas
number
requir
specimen
detect
pathogen
may
part
initi
diagnost
differenti
owe
rariti
agent
inaccess
altern
inhous
test
method
provid
result
clinic
action
timefram
incorpor
molecular
multiplex
panel
financi
logist
benefit
laboratori
specif
one
decreas
number
method
need
detect
divers
infecti
agent
decreas
technologist
handson
time
result
simplifi
workflow
purpos
train
compet
use
often
cost
patient
assay
provid
superior
accuraci
tradit
approach
greater
breadth
target
pathogen
may
decreas
number
medic
visit
intervent
durat
diagnosi
certain
multiplex
assay
provid
benefit
beyond
direct
patient
care
earli
recognit
drugresist
pathogen
swift
implement
infect
control
measur
improv
detect
gastrointestin
pathogen
may
impact
outbreak
investig
final
rapid
pathogen
detect
potenti
improv
earli
intervent
shown
posit
impact
associ
cost
aid
select
test
use
reduc
length
stay
taken
togeth
benefit
molecular
syndrom
panel
poc
test
vastli
outweigh
disadvantag
center
around
cost
health
care
system
name
hospit
patient
claim
socal
shotgun
approach
add
unnecessari
cost
patient
oversimplif
although
molecular
multiplex
assay
often
costli
term
reagent
patient
bill
compar
singl
cultureor
serologybas
assay
multipl
diagnost
test
order
multiplex
assay
often
less
expens
full
batteri
tradit
test
anecdot
physician
desir
provid
patient
definit
diagnosi
treatment
plan
may
inadvert
lead
overus
medic
resourc
injudici
antibiot
use
addit
diagnost
test
eg
imag
help
establish
diagnosi
caus
pathogen
easili
identifi
therefor
abil
rapidli
accur
provid
caus
patient
ill
may
improv
physician
patient
satisfact
present
fdaclear
syndrom
poc
molecular
assay
center
around
syndrom
howev
menu
like
expand
come
year
laboratori
rapidli
adopt
approach
test
combin
consult
eg
antimicrobi
stewardship
intervent
implement
assay
shown
decreas
time
appropri
therapi
improv
patient
surviv
decreas
overal
health
careassoci
cost
care
must
taken
select
appropri
use
multiplex
panel
specif
one
must
balanc
potenti
increas
laboratori
reagent
equip
cost
potenti
reduc
labor
cost
increas
revenu
provid
highest
qualiti
care
limit
unnecessari
expens
laboratori
must
develop
algorithm
assist
provid
test
order
use
